Thyroid cancer trials in Canada

In Canada 8 Also abroad 226

8 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseNot yet taking people in Canada
A Comparison of [68Ga]DOTATATE and [18F]AmBF3TATE for the Staging and Assessment of Neuroendocrine Malignancies
Where
Vancouver
Age
18 years and over
People
60
Run by
British Columbia Cancer Agency
See details and how to joinNCT07621146
Phase 1Taking people
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
Where
Montreal
Age
18 years to 100 years
People
116 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07006727 · EU 2024-519111-34-00
Phase 2Taking people
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Where
Montreal, Toronto
Age
8 years and over
People
254 worldwide
Run by
Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00
Phase 1/2Taking people
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Where
Edmonton, Ontario, Ottawa, Toronto, Vancouver
Age
12 years and over
People
500 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00
No phaseTaking people
Radiofrequency Ablation for Curative Treatment of Small Low-Risk Papillary Thyroid Cancer: Pilot Study
Where
Toronto
Age
18 years and over
People
30
Run by
University Health Network, Toronto
See details and how to joinNCT07376837
No phaseTaking people
Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples
Where
Calgary
Age
18 years and over
People
130
Run by
University of Calgary
See details and how to joinNCT06133374
Phase 2Taking people
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Where
Edmonton, Montreal, Toronto, Winnipeg
Age
18 years and over
People
497 worldwide
Run by
Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00
No phaseTaking people
The Safety and Feasibility of Radiofrequency Ablation to Treat Low-risk Thyroid Cancer
Where
Toronto
Age
18 years to 100 years
People
40
Run by
University Health Network, Toronto
See details and how to joinNCT06929650